• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
855.7849313
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
37.82
60513.73
EPS(TTM)
Face Value()
Div & Yield %
56.7
1
0.12
 

Shilchar Technologies standalone net profit declines 48.72% in the March 2026 quarter
May 06,2026
Net profit of Shilchar Technologies declined 48.72% to Rs 28.39 crore in the quarter ended March 2026 as against Rs 55.36 crore during the previous quarter ended March 2025. Sales declined 34.59% to Rs 151.65 crore in the quarter ended March 2026 as against Rs 231.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.70% to Rs 158.16 crore in the year ended March 2026 as against Rs 146.85 crore during the previous year ended March 2025. Sales rose 4.62% to Rs 651.94 crore in the year ended March 2026 as against Rs 623.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales151.65231.86 -35 651.94623.15 5
OPM %21.0530.72 -29.2129.65 -
PBDT38.4975.66 -49 215.99200.78 8
PBT37.4874.68 -50 211.97197.37 7
NP28.3955.36 -49 158.16146.85 8